CLINICAL DATA PGxHEALTH DIVISION
Clinical Data: From Targeted Science to Better Healthcare.

Stock Information
CLDA - (NASDAQ)
$16.01   + 0.17
Sep 8, 2010
12:36 PM ET

Clinical Data: From Targeted Science to Better Healthcare.
About UsInvestorsContact Us
Print Print page    E-mail E-mail page
SEC Filings
Add to Briefcase = Add Filing to Briefcase
  
Filing Description Date Filed Sorted Ascending Size  
DEF 14A definitive proxy statement Jul 28, 1995 69.2 KB Add to Briefcase
10-Q quarterly report Aug 7, 1995 63.9 KB Add to Briefcase
10-Q quarterly report Nov 13, 1995 68.5 KB Add to Briefcase
10-Q quarterly report Feb 8, 1996 64.1 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 8, 1996 25.6 KB Add to Briefcase
10-K annual report Jun 26, 1996 181.7 KB Add to Briefcase
DEF 14A definitive proxy statement Jul 25, 1996 75.0 KB Add to Briefcase
10-Q quarterly report Aug 7, 1996 63.4 KB Add to Briefcase
SC 13D/A amended general statement of beneficial ownership Oct 9, 1996 24.8 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Nov 12, 1996 24.4 KB Add to Briefcase
10-Q quarterly report Nov 13, 1996 72.8 KB Add to Briefcase
SC 13D general statement of beneficial ownership Jan 22, 1997 46.4 KB Add to Briefcase
SC 13D general statement of beneficial ownership Jan 24, 1997 74.6 KB Add to Briefcase
10-Q quarterly report Feb 3, 1997 77.4 KB Add to Briefcase
SC 13D/A amended general statement of beneficial ownership Apr 14, 1997 35.9 KB Add to Briefcase
SC 13D/A amended general statement of beneficial ownership May 21, 1997 36.5 KB Add to Briefcase
SC 13D/A amended general statement of beneficial ownership May 23, 1997 47.6 KB Add to Briefcase
10-K annual report Jun 27, 1997 197.4 KB Add to Briefcase
SC 13D/A amended general statement of beneficial ownership Jun 30, 1997 37.1 KB Add to Briefcase
DEF 14A definitive proxy statement Jul 21, 1997 75.1 KB Add to Briefcase
Showing 1-20 of 521 filings Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  See Next 20
Investors:


  Shareholder Tools